sentence
stringlengths
0
960
entities
listlengths
0
23
data_source
stringclasses
3 values
These results suggest that both endodermal and mesodermal precursors exist in EBs with FGF withdrawal for 8 days.
[ { "end": 68, "label": "CellType", "start": 47, "text": null }, { "end": 81, "label": "Tissue", "start": 78, "text": null }, { "end": 68, "label": "CellType", "start": 58, "text": null }, { "end": 42, "label": "Tissue", "start": 32, "text": null }, { "end": 57, "label": "Tissue", "start": 47, "text": null } ]
CellFinder
However, no PDX-1-positive cells were seen in EBs differentiated with the same treatment (data not shown).Figure 4Differentiated EBs were analyzed by either immunocytochemistry or RT-PCR to the indicated molecular markers. (
[ { "end": 49, "label": "Tissue", "start": 46, "text": null }, { "end": 49, "label": "Tissue", "start": 46, "text": null }, { "end": 132, "label": "Tissue", "start": 129, "text": null }, { "end": 132, "label": "Tissue", "start": 129, "text": null } ]
CellFinder
A) Immunostaining with goat anti-human SOX17 (Red), is contrasted with Fluoro Nissl nuclear staining (Green). (
[]
CellFinder
B) Immunostaining with goat anti-human GATA6 (Red), is contrasted with DAPI nuclear staining (Blue). (
[]
CellFinder
C) Immunostaining with goat anti-human brachyury (Red), is contrasted with DAPI nuclear staining (Blue). (
[]
CellFinder
D) Immunostaining with mouse anti-human GATA1 (Red).
[]
CellFinder
Note that each antibody recognizes subsets of EB cells.
[ { "end": 54, "label": "CellType", "start": 46, "text": null } ]
CellFinder
Scale bars = 100 μm. (
[]
CellFinder
E) The differentiation status of EB is detected by RT-PCR using different germ layer cell markers.
[ { "end": 89, "label": "CellType", "start": 74, "text": null }, { "end": 84, "label": "Tissue", "start": 74, "text": null } ]
CellFinder
Selected endoderm markers AFP, FoxA2; mesoderm markers Hand1, MSX1 and ectoderm marker Msl1 were all highly expressed in the EB samples while their expression was either undetectable or at low level in the ES samples.
[ { "end": 208, "label": "CellType", "start": 206, "text": null }, { "end": 79, "label": "Tissue", "start": 71, "text": null }, { "end": 46, "label": "Tissue", "start": 38, "text": null }, { "end": 17, "label": "Tissue", "start": 9, "text": null } ]
CellFinder
G3PDH was a positive control showing similar amount of RNA samples were used for analysis.
[]
CellFinder
Examination of cross-reactivity of antibodies on mouse ES and differentiated cellsWe have also examined the cross-reactivities of these antibodies to mouse ES cells using mouse D3 ES cell line and mouse fetal endodermal tissue.
[ { "end": 187, "label": "CellType", "start": 171, "text": null }, { "end": 208, "label": "Tissue", "start": 203, "text": null }, { "end": 219, "label": "Tissue", "start": 209, "text": null }, { "end": 179, "label": "CellLine", "start": 177, "text": null }, { "end": 164, "label": "CellType", "start": 150, "text": null }, { "end": 164, "label": "CellType", "start": 156, "text": null }, { "end": 57, "label": "CellType", "start": 55, "text": null }, { "end": 57, "label": "CellType", "start": 49, "text": null } ]
CellFinder
Cross-reactivity to mouse of goat anti-Oct3/4, goat anti-PDX-1, goat anti-SOX17 and mouse anti-SOX2 was detected.
[]
CellFinder
Minimal cross-reactivity to mouse, measured by 10% intensity to human by higher than control cells, was observed in mouse anti-CD9 and mouse anti-E-cadherin antibodies.
[]
CellFinder
Goat anti-Nanog and mouse anti-PODXL antibodies appear to be human-specific as well (data not shown).
[]
CellFinder
The subtypes of monoclonal antibodies were also identified in the best clones.
[]
CellFinder
These results are summarized in Table 2.Table 2Summary of antibodies detection in ES and EB samples.
[ { "end": 84, "label": "CellType", "start": 82, "text": null } ]
CellFinder
AntibodyESEBReactivity to mouseIsotype of monoclonal antibody (Clone No.)Gt × hBrachyuryNoYesNT*Ms × hDPPA5YesNT*NT*ND*Gt × hGATA6NoYesNT*Gt × hNanogYesDownNoGt × hOct 3/4YesDownYesGt × hPDX-1NoNoYesGt × hSOX17NoYesYesMs × hCD9YesNoMinimalMouse IgG2B (clone 209306)Ms × hE-cadherinYesNoMinimalMouse IgG2B (clone 180224)Ms × hGATA1NoYesNT*Rat IgG2B (clone 234732)Ms × hPODXLYesNoNoMouse IgG2A (clone 222328)Ms × hSOX2YesYesYesMouse IgG2A (clone 245610)*NT, Not tested; ND, Not determined.
[]
CellFinder
The expression patterns detected using antibodies developed in our facility are consistent with data reported using reverse transcriptase-polymerase chain reaction or cDNA microarrays.
[]
CellFinder
Moreover several of the monoclonal antibodies have differing heavy chain subunits allowing double labeling using subtype specific markers to be performed.
[]
CellFinder
In summary, we have developed a useful collection of antibodies that would be useful for identification of stem cell characteristics and assessment of differentiation.
[]
CellFinder
Several additional antibodies to the molecules that have been identified as potential cell lineage markers [13] are currently under development using the same approach.
[]
CellFinder
Cloning and expression of Brachyury, DPPA5, CD9, E-Cadherin, GATA1, GATA6, Nanog, Oct3/4, PDX-1, PODXL, SOX2 and SOX17Brachyury (aa.
[]
CellFinder
1–202), DPPA5 (a.a.
[]
CellFinder
1–116), GATA1 (a.a.
[]
CellFinder
1–413), GATA6 (aa.
[]
CellFinder
1–449), Nanog (aa.
[]
CellFinder
153–305), Oct3/4 (aa.
[]
CellFinder
1–265), PDX-1 (aa.
[]
CellFinder
1–283), SOX2 (aa.
[]
CellFinder
135–317) and SOX17 (aa.
[]
CellFinder
177–414) were expressed in E. Coli and extracellular domains of CD9, E-Cadherin, PODXL were expressed in mouse NSO cells.
[ { "end": 120, "label": "CellType", "start": 105, "text": null }, { "end": 120, "label": "CellType", "start": 111, "text": null } ]
CellFinder
All proteins were purified and sequenced before they were used as antigens for immunizations and as substrate for antibody screening and subcloning.
[]
CellFinder
Production and purification of antibodiesAll monoclonal antibodies were derived from fusions of mouse myeloma with B cells obtained from BALB/c mice which had been immunized with purified antigen.
[ { "end": 122, "label": "CellType", "start": 115, "text": null }, { "end": 109, "label": "Tissue", "start": 96, "text": null } ]
CellFinder
The IgG fraction of the culture supernatant was purified by Protein G affinity chromatography (Sigma).
[]
CellFinder
Each panel of antibodies was screened and selected for their abilities to detect purified recombinant antigen in direct ELISA and Western blot.
[]
CellFinder
All polyclonal antibodies were derived from sera of goats which had been immunized and boost it with purified antigen.
[]
CellFinder
Antibody was purified from the sera by an antigen-affinity chromatography.
[]
CellFinder
Cells and cell cultureHuman Caco-2, MG-63, MCF-7, NTERA-2 and mouse D3 cells were purchased from American Type Culture Collection (ATCC).
[ { "end": 34, "label": "CellLine", "start": 28, "text": null }, { "end": 76, "label": "CellType", "start": 62, "text": null }, { "end": 70, "label": "CellLine", "start": 68, "text": null }, { "end": 57, "label": "CellLine", "start": 50, "text": null }, { "end": 48, "label": "CellLine", "start": 43, "text": null }, { "end": 41, "label": "CellLine", "start": 36, "text": null } ]
CellFinder
Cells were cultured according to the ATCC instructions.
[]
CellFinder
Information regarding human ES cell line HSF-6 (NIH code UC06) can be obtained at the website [14].
[ { "end": 34, "label": "CellType", "start": 28, "text": null }, { "end": 46, "label": "CellLine", "start": 41, "text": null }, { "end": 61, "label": "CellLine", "start": 57, "text": null } ]
CellFinder
Undifferentiated human ES cells were cultured according to the protocol provided by the University of California, San Francisco in human ES culture medium [DMEM supplemented with 20% KnockOut Serum Replacement (Invitrogen) and 5 ng/mL of bFGF (R&D Systems)].
[ { "end": 31, "label": "CellType", "start": 23, "text": null }, { "end": 139, "label": "CellType", "start": 137, "text": null } ]
CellFinder
To induce formation of embryoid bodies (EBs), ES colonies were harvested, separated from the MEF feeder cells by gravity, gently resuspended in ES culture medium and transferred to non-adherent suspension culture dishes (Corning).
[ { "end": 212, "label": "Tissue", "start": 205, "text": null }, { "end": 57, "label": "Tissue", "start": 49, "text": null }, { "end": 38, "label": "Tissue", "start": 23, "text": null }, { "end": 43, "label": "Tissue", "start": 40, "text": null }, { "end": 48, "label": "CellType", "start": 46, "text": null }, { "end": 96, "label": "CellType", "start": 93, "text": null }, { "end": 146, "label": "CellType", "start": 144, "text": null }, { "end": 109, "label": "CellType", "start": 97, "text": null }, { "end": 154, "label": "Tissue", "start": 147, "text": null } ]
CellFinder
Unless otherwise noted, EBs derived from human ES cell aggregates were cultured for 8 days in ES culture medium deprived of bFGF and used for analysis by immunohistochemistry as described.
[ { "end": 27, "label": "Tissue", "start": 24, "text": null }, { "end": 65, "label": "Tissue", "start": 55, "text": null }, { "end": 96, "label": "CellType", "start": 94, "text": null } ]
CellFinder
Western blotCells are solubilized in hot 2× SDS gel sample buffer (20 mM dithiothreitol, 6% SDS, 0.25 M Tris, pH 6.8, 10% glycerol, 10 mM NaF and bromophenyl blue) at 2 × 106 per mL. The extracts are heated in a boiling water bath for 5 minutes and sonicated with a probe sonicator with 3–4 bursts of 5–10 seconds each.
[]
CellFinder
Samples are diluted with 1× SDS sample buffer to the desired loading of 1–5 × 103 per lane.
[]
CellFinder
Lysates were resolved by SDS-PAGE, transferred to Immobilon-P membrane, and immunoblotted with 0.5 μg/mL primary Abs as described in R&D Systems Website [15].
[]
CellFinder
ImmunohistochemistryAntibodies were used with the appropriate secondary reagents at a concentration of 5 to 10 μg/ml.
[]
CellFinder
Cells or sections of EBs were fixed with 4% paraformaldehyde in PBS at room temperature for 20 min, then blocked and permeabilized with 0.1% Triton X-100, 1% BSA, 10% normal donkey serum in PBS at room temperature for 45 min.
[ { "end": 24, "label": "Tissue", "start": 21, "text": null } ]
CellFinder
After blocking, cells were incubated with diluted primary antibody overnight at 4°C followed by coupled anti-mouse or anti-goat IgG (Molecular Probes) at room temperature in the dark for an hour.
[]
CellFinder
Between each step cells were washed with PBS with 0.1% BSA.
[]
CellFinder
RT-PCRTotal RNA was extracted from EBs using Trizol LS (Invitrogen).
[ { "end": 38, "label": "Tissue", "start": 35, "text": null } ]
CellFinder
cDNA was synthesized by using Superscript II reverse transcriptase (Invitrogen) according to the manufacturer's recommendations.
[]
CellFinder
The PCR primers are available upon request.
[]
CellFinder
Flow cytometryAntibodies were prepared at the concentration of 0.1 mg/mL. 10 μL of the stock solution was added to 1 – 2.5 × 105 cells in a total reaction volume not exceeding 200 μL. The sample was then incubated for 20 min at 2–8 °C.
[]
CellFinder
Following incubation, excess antibody was removed by washing cells twice with FACS buffer (2% FCS and 0.1% sodium azide in Hank's buffer).
[]
CellFinder
After wash, cells were resuspend in 200 μL of FACS buffer and the binding of unlabeled monoclonal antibodies was visualized by adding 10 μL of a 25 μg/mL stock solution of a secondary developing reagent such as goat anti-mouse IgG conjugated to a fluorochrome for 20 min at 2–8°C.
[]
CellFinder
Following incubation, cells were washed once with FACS buffer, once with PBS.
[]
CellFinder
After wash, cells were resuspend in 400 μL of PBS and analyzed on a FACScant flow cytometer (Becton-Dickinson, Mountain View, CA).
[]
CellFinder
Five thousand events were collected and analyzed using CELL Quest software.
[]
CellFinder
[]
CellFinder